跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,264 条关于
“RAF mutations”
全部
8,264
临床试验
5,020
药物
320
机构
23
资讯
2,901
去年
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
去年
Servier and Black Diamond Therapeutics Forge $780M Global Licensing Deal for Novel RAF/RAS Cancer Therapy
去年
Immuneering's IMM-1-104 Shows Promise in Pancreatic Cancer, Gains FDA Support
去年
Pasithea Therapeutics Expands PAS-004 Clinical Trial to Europe, Completes Dosing in Cohort 4A
去年
Immuneering Partners with Regeneron to Test Novel Cancer Drug Combination for Advanced Lung Cancer
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
2年前
Sysmex Inostics' RAS-RAF-SEQ Assay Gains New York Approval for Clinical Trial Use
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
去年
IRIC and Ipsen Initiate Phase 1 Trial of RAF Inhibitor IPN01195 for Solid Tumors
去年
Lutris Pharma to Present Phase 2 Results of Novel B-Raf Inhibitor for EGFR Inhibitor-Induced Skin Rash at AACR 2025
第 1 页,共 291 页
上一页
下一页